These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18661762)

  • 1. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
    Zeng HS; Xiong XY; Wei YD; Wang HW; Luo XP
    World J Pediatr; 2008 May; 4(2):97-101. PubMed ID: 18661762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.
    Singh S; Chandrakasan S; Ahluwalia J; Suri D; Rawat A; Ahmed N; Das R; Sachdeva MU; Varma N
    Rheumatol Int; 2012 Apr; 32(4):881-6. PubMed ID: 21221591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: analysis of 13 patients].
    Shi H; Wang HW; Cheng PX; Hu XF; Liu QJ; Wan LJ
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):812-7. PubMed ID: 17274866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and perforin A91V gene analysis in 31 patients with macrophage activation syndrome and systemic juvenile idiopathic arthritis in China.
    Huasong Z; Ping W; Xiangyuan C; Yandan W
    J Rheumatol; 2013 Jul; 40(7):1238-9. PubMed ID: 23818729
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review.
    Kumar S; Vaidyanathan B; Gayathri S; Rajam L
    Rheumatol Int; 2013 Apr; 33(4):1065-9. PubMed ID: 21132551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis].
    Li CF; He XH; Kuang WY; Han TX; Zhou YF
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):806-11. PubMed ID: 17274865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
    Juneja M; Jain R; Mishra D
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Shimizu M; Mizuta M; Okamoto N; Yasumi T; Iwata N; Umebayashi H; Okura Y; Kinjo N; Kubota T; Nakagishi Y; Nishimura K; Mohri M; Yashiro M; Yasumura J; Wakiguchi H; Mori M
    Pediatr Rheumatol Online J; 2020 Jan; 18(1):2. PubMed ID: 31924225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
    Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
    Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease.
    Dong S; Bout-Tabaku S; Texter K; Jaggi P
    J Pediatr; 2015 May; 166(5):1283-8. PubMed ID: 25771391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review.
    Liquidano-Perez E; Maza-Ramos G; Salazar-Bailón JL; Yamazaki-Nakashimada MA; Rivas-Larrauri F
    Rheumatol Int; 2023 Jan; 43(1):183-189. PubMed ID: 36264324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
    Kaufman KM; Linghu B; Szustakowski JD; Husami A; Yang F; Zhang K; Filipovich AH; Fall N; Harley JB; Nirmala NR; Grom AA
    Arthritis Rheumatol; 2014 Dec; 66(12):3486-95. PubMed ID: 25047945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of PatientsWith Systemic Onset Juvenile Idiopathic Arthritis With Macrophage Activation Syndrome at Onset.
    Raghuram J; Gornale VK; Rao AP
    Indian Pediatr; 2021 Jan; 58(1):87. PubMed ID: 33452788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.